[ Ссылка ] ► Increasingly, doctors have prescribed intravenous treatments with drugs known as monoclonal antibodies to prevent hospitalization for patients with COVID-19.
Throughout Texas, the state has opened regional infusion centers to provide monoclonal antibody treatment for infected patients age 12 and older who have mild-to-moderate symptoms, meet certain criteria and have a doctor’s prescription.
In this video, Dr. Jan Patterson, an infectious disease expert at University Health and UT Health San Antonio, explains how these manmade antibodies attack the COVID-19 spike protein and prevent the virus from entering the cell.
While they are not an alternative to vaccination, Dr. Patterson says monoclonal antibodies have proven to be effective in preventing the progression of the disease in many patients with mild-to-moderate COVID-19 symptoms.
00:00 - Monoclonal antibodies are now being used to treat patients with COVID-19. What are they?
00:19 - Which patients qualify for monoclonal antibody treatment?
01:01 - How does a patient gain access to monoclonal antibody infusions?
01:39 - How effective are monoclonal antibodies in keeping COVID-19 patients out of hospitals?
02:23 - How does the COVID-19 vaccine affect your eligibility for monoclonal antibody treatment?
03:04 - Are monoclonal antibodies a substitute for COVID-19 vaccination?
